Search results
Results From The WOW.Com Content Network
Bronchospasm or a bronchial spasm is a sudden constriction of the muscles in the walls of the bronchioles. It is caused by the release ( degranulation ) of substances from mast cells or basophils under the influence of anaphylatoxins .
Bronchopulmonary dysplasia (BPD; part of the spectrum of chronic lung disease of infancy) is a chronic lung disease which affects premature infants.Premature (preterm) infants who require treatment with supplemental oxygen or require long-term oxygen are at a higher risk. [1]
Prolonged apnea refers to a patient who has stopped breathing for a long period of time. If the heart muscle contraction is intact, the condition is known as respiratory arrest. An abrupt stop of pulmonary gas exchange lasting for more than five minutes may permanently damage vital organs, especially the brain .
It is used for its neuro-protective effects since it is shown to decrease the risk of cerebral palsy in infants. [41] Absolute contraindication: myasthenia gravis. [42] Use as a tocolytic agent may result in death of the fetus or infant. [40] Flushing, lethargy, headache, muscle weakness, diplopia, dry mouth, pulmonary edema, cardiac arrest [42]
[13] [15] Pneumonia is also the leading cause of death in children less than five years of age in low income countries. [15] The most common cause of pneumonia is pneumococcal bacteria, Streptococcus pneumoniae accounts for 2/3 of bacteremic pneumonias. [16] Invasive pneumococcal pneumonia has a mortality rate of around 20%. [14]
When children are experiencing poor feeding or dehydration, the child may be admitted to the hospital. [9] [20] [15] Approximately 50% of infants who are hospitalized due to bronchiolitis require fluid therapy. [37] There are two main approaches to fluid therapy: intravenous (IV) fluid therapy and enteral tube fluid therapy (nasogastric or ...
Transient tachypnea of the newborn occurs in approximately 1 in 100 preterm infants and 3.6–5.7 per 1000 term infants. It is most common in infants born by caesarian section without a trial of labor after 35 weeks of gestation. Male infants and infants with an umbilical cord prolapse or perinatal asphyxia are at higher risk.
The issue of bronchospasm acquired prominence in the neuromuscular-blocking agents arena after the withdrawal from clinical use of rapacuronium (Raplon - a steroidal neuromuscular-blocking agent marketed by Organon) in 2001 [9] [10] after several serious events of bronchospasm, [11] [12] including five unexplained fatalities, [13] following its ...